Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Biotech
Obesity biotech Metsera files for a swift IPO
Obesity biotech Metsera has filed for an IPO nine months after emerging, with the funds slated to fuel a late-stage trial.
Gabrielle Masson
Jan 11, 2025 9:05am
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
Oct 15, 2024 11:12am
UPDATE: Lilly-backed metabolic disease biotech files IPO
Sep 4, 2024 10:23am
GLP-1 liraglutide reduces cognitive decline in Alzheimer's
Jul 30, 2024 1:29pm
A look at the R&D landscape in obesity, led by GLP-1s
Mar 19, 2024 8:00am
Vivani's exenatide implant boosts weight loss as well as Wegovy
Mar 1, 2024 10:00am